Drugs / Alcohol
Alcohol
English name ethanol
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | ALCOHOL 5% AND DEXTROSE 5% | — | 1946-01-17 | fda.gov ↗ |
Trials 53
19441945194619471948194919501951195219531954195519561957195819591960196119621963196419651966196719681969197019711972197319741975197619771978197919801981198219831984198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026202720282029203020312032
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 011 trials | ||||||
| Phase 0 | NCT06326684 | Jun 2024 → Mar 2027 expected | alcohol-related disorders | William Stoops | Recruiting | No outcome recorded |
| Phase 0 | NCT05929677 | Apr 2024 → Sep 2027 expected | alcohol-related disorders | Jessica Weafer | Recruiting | No outcome recorded |
| Phase 0 | NCT05826951 | Feb → Oct 2023 | alcohol-related disorders | University of Chicago | Completed | No outcome recorded |
| Phase 0 | NCT06135844 | Apr 2022 → Nov 2023 | herpes labialis, herpes simplex type 1 infectious disease | Leciel Bono | Unknown | No outcome recorded |
| Phase 0 | NCT04856566 | Jul 2021 → Aug 2023 | alcohol-induced mental disorder | Yale University | Completed | No outcome recorded |
| Phase 0 | NCT04159688 | Mar 2020 → Jun 2022 | alcohol-related disorders | Yale University | Completed | No outcome recorded |
| Phase 0 | NCT04299373 | Feb 2020 → Sep 2022 | — | University of Missouri-Columbia | Terminated | No outcome recorded |
| Phase 0 | NCT04251221 | Jun 2019 → Nov 2021 | alcohol-related disorders | Yale University | Completed | No outcome recorded |
| Phase 0 | NCT03467191 | Feb 2018 → Jul 2022 overdue | alcohol abuse, alcohol dependence | Carnegie Mellon University | Active not recruiting | No outcome recorded |
| Phase 0 | NCT03216954 | Sep 2017 → Apr 2020 | alcohol-related disorders | William Stoops | Completed | No outcome recorded |
| Phase 0 | NCT03037749 | Sep 2015 → Aug 2018 | — | University of New Mexico | Completed | No outcome recorded |
| Phase 116 trials | ||||||
| Phase 1 | NCT07176208 | Dec 2025 → Apr 2026 overdue | cannabis dependence | Food and Drug Administration (FDA) | Recruiting | No outcome recorded |
| Phase 1 | NCT06798038 | Mar 2025 → Feb 2027 expected | osteoarthritis, knee | Tanta University | Not yet recruiting | No outcome recorded |
| Phase 1 | NCT06712602 | Feb 2025 → Jul 2028 expected | alcohol-related disorders | Pop Test Oncology LLC | Recruiting | No outcome recorded |
| Phase 1 | NCT06293040 | Sep 2024 → Aug 2027 expected | alcohol-related disorders | Johns Hopkins University | Recruiting | No outcome recorded |
| Phase 1 | NCT06703437 | Dec 2022 → Feb 2023 overdue | prostate cancer | Icahn School of Medicine at Mount Sinai | Active not recruiting | No outcome recorded |
| Phase 1 | NCT05316428 | Feb → Apr 2022 | alcohol-related disorders, erectile dysfunction | Vigonvita Life Sciences | Completed | No outcome recorded |
| Phase 1 | NCT04931095 | Feb 2022 → Aug 2025 | alcohol-related disorders | Johns Hopkins University | Completed | No outcome recorded |
| Phase 1 | NCT04300751 | Mar 2021 → Nov 2024 | alcohol-related disorders | Sharon Walsh | Completed | No outcome recorded |
| Phase 1 | NCT04003402 | Jul → Oct 2019 | — | Astellas Pharma Global Development, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT03483636 | Mar → Sep 2018 | — | Eisai Inc. | Completed | No outcome recorded |
| Phase 1 | NCT03361384 | May 2016 → Jun 2020 | alcohol-related disorders | Syracuse University | Completed | No outcome recorded |
| Phase 1 | NCT01289561 | Jan 2011 → Jan 2015 | alcohol-induced mental disorder | Johns Hopkins University | Completed | No outcome recorded |
| Phase 1 | NCT02126917 | Nov → Dec 2009 | — | Zogenix, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT00879047 | Apr 2009 → Apr 2013 | HIV infectious disease, hepatitis C virus infection | University of California, San Francisco | Completed | No outcome recorded |
| Phase 1 | NCT00713492 | Oct 2008 → Dec 2023 | alcohol-induced mental disorder | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Completed | No outcome recorded |
| Phase 1 | NCT01241032 | Jun 2006 → Feb 2007 | erectile dysfunction | Asan Medical Center | Completed | No outcome recorded |
| Phase 1/22 trials | ||||||
| Phase 1/2 | NCT05273658 | Aug 2022 → Jun 2023 | alcohol-related disorders | University of California, San Diego | Withdrawn | No outcome recorded Stop: Business |
| Phase 1/2 | NCT00037141 | Mar 2002 → Mar 2004 | benign prostatic hyperplasia | American Medical Systems | Completed | No outcome recorded |
| Phase 24 trials · 1 missed | ||||||
| Phase 2 | NCT05389930 | Mar 2023 → Mar 2027 expected | alcohol-related disorders | Brown University | Recruiting | No outcome recorded |
| Phase 2 | NCT03503773 | Sep 2018 → Jan 2022 | essential hypertension | Ablative Solutions, Inc. | Completed | Missed primary |
| Phase 2 | NCT00183170 | Feb 2004 → Jan 2009 | alcohol-related disorders | Boston University | Completed | No outcome recorded |
| Phase 2 | NCT00001925 | Jan 1999 → Jul 2002 | movement disorder | National Institute of Neurological Disorders and Stroke (NINDS) | Completed | No outcome recorded |
| Phase 32 trials · 1 met primary | ||||||
| Phase 3 | NCT02910414 | Jul 2019 → Dec 2023 overdue | hypertensive disorder | Ablative Solutions, Inc. | Active not recruiting | Met primary |
| Phase 3 | NCT03131843 | May 2017 → Dec 2018 | skin infection | University of Toronto | Unknown | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT05798936 | Apr 2023 → May 2025 | benign thyroid gland neoplasm | Assiut University | Unknown | No outcome recorded |
| Phase 4 | NCT00578279 | Mar 2007 → Jun 2009 | malignant pancreatic neoplasm | Indiana University | Completed | No outcome recorded |
| Phase not applicable16 trials · 1 met primary | ||||||
| — | NCT07125534 | Aug 2025 → Jan 2027 expected | alcohol abuse, alcohol dependence | University of Illinois at Urbana-Champaign | Recruiting | No outcome recorded |
| — | NCT06627803 | Feb 2025 → Aug 2029 expected | alcohol-related disorders | University of Southern California | Recruiting | No outcome recorded |
| — | NCT06822257 | Feb 2025 → Sep 2029 expected | alcohol-related disorders | Carnegie Mellon University | Recruiting | No outcome recorded |
| — | NCT06520384 | Jul 2024 → Jan 2025 | osteoarthritis, knee | Tanta University | Completed | No outcome recorded |
| — | NCT05973656 | Jul 2022 → Nov 2026 expected | Fanconi anemia, oral cavity carcinoma | Masonic Cancer Center, University of Minnesota | Recruiting | No outcome recorded |
| — | NCT04929288 | May 2021 → Jun 2027 expected | alcohol-related disorders | Jessica Weafer | Recruiting | No outcome recorded |
| — | NCT04595682 | Mar 2021 → Nov 2024 | alcohol-related disorders | Mark Fillmore | Completed | No outcome recorded |
| — | NCT04230460 | Sep 2020 → May 2021 | alcohol-induced mental disorder, poisoning | Advanced Brain Monitoring, Inc. | Completed | No outcome recorded |
| — | NCT04543942 | Nov 2019 → May 2023 | alcohol abuse | Mark Fillmore | Completed | No outcome recorded |
| — | NCT03449095 | Nov 2017 → Jul 2023 | alcohol abuse, alcohol dependence, alcohol-induced mental disorder | University of Illinois at Urbana-Champaign | Completed | Met primary |
| — | NCT02542150 | Sep 2015 → Mar 2017 | — | University of Colorado, Denver | Completed | No outcome recorded |
| — | NCT02049268 | Jul 2013 → Dec 2015 | alcohol and nicotine codependence | Mclean Hospital | Completed | No outcome recorded |
| — | NCT01620177 | Jul 2012 → Mar 2014 | alcohol-related disorders | Gary R Gaffney | Completed | No outcome recorded |
| — | NCT00477984 | May 2007 → Mar 2008 | alcohol dependence | Utrecht Institute for Pharmaceutical Sciences | Completed | No outcome recorded |
| — | NCT00305292 | Mar → Aug 2006 | alcohol-related disorders | University of California, San Francisco | Terminated | No outcome recorded |
| — | NCT00167115 | Dec 2004 → Sep 2005 | type 2 diabetes mellitus | Bantle, John P., MD | Completed | No outcome recorded |
| Comparator or background therapy21 trials | ||||||
| Phase 0 | NCT03736343 Comparator | May 2019 → May 2020 | alcohol-related disorders | University of Florida | Terminated | No outcome recorded Stop: Enrollment |
| Phase 0 | NCT03106363 Comparator | Jul 2017 → Jan 2020 | — | Centre for Addiction and Mental Health | Completed | No outcome recorded |
| Phase 1 | NCT03699540 Comparator | Jul 2019 → Dec 2022 | alcohol-related disorders, cannabis dependence | Shanna Babalonis, PhD | Completed | No outcome recorded |
| Phase 1 | NCT03827460 Background | Apr 2019 → Aug 2026 overdue | alcohol dependence | Indiana University | Recruiting | No outcome recorded |
| Phase 1 | NCT03575403 Comparator | Sep 2018 → Mar 2023 | alcohol-related disorders | Craig Rush | Completed | No outcome recorded |
| Phase 1 | NCT04155697 Comparator | Jun 2017 → Sep 2018 | — | The University of Texas Health Science Center, Houston | Completed | No outcome recorded |
| Phase 1 | NCT02294266 Comparator | Dec 2014 → Mar 2015 | alcohol-related disorders | Parc de Salut Mar | Completed | No outcome recorded |
| Phase 1 | NCT02033707 Background | Apr 2014 → Feb 2019 | — | Johns Hopkins University | Completed | No outcome recorded |
| Phase 1 | NCT01638364 Comparator | Jan 2013 → Jun 2015 | alcohol abuse | Centre for Addiction and Mental Health | Completed | No outcome recorded |
| Phase 1 | NCT01531920 Background | May 2010 → Apr 2011 | central nervous system disorder | Eisai Inc. | Completed | No outcome recorded |
| Phase 2 | NCT01779024 Background | Dec 2012 → Jun 2017 | alcohol dependence | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Completed | Met primary |
| Phase 2 | NCT00295334 Comparator | Jun 2010 → May 2012 | type 2 diabetes mellitus | Iris Shai | Completed | No outcome recorded |
| Phase 3 | NCT02414581 Comparator | Apr 2015 → Aug 2016 | neutropenia | Hospital Regional de Alta Especialidad del Bajio | Completed | No outcome recorded |
| Phase 3 | NCT00559819 Comparator | Feb 2008 → Mar 2022 | poisoning | Rush University Medical Center | Completed | No outcome recorded |
| Phase 4 | NCT04801082 Comparator | Mar 2021 → Jan 2024 | cancer | The University of Hong Kong | Unknown | No outcome recorded |
| Phase 4 | NCT02488889 Comparator | Aug 2015 → Jul 2016 | alcohol-related disorders | University of California, Los Angeles | Withdrawn | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT01844141 Comparator | Jan → Apr 2013 | nail disorder | Universidad Complutense de Madrid | Unknown | No outcome recorded |
| — | NCT07421323 Comparator | Aug 2025 → Mar 2026 overdue | neonatal sepsis | Alexandria University | Recruiting | No outcome recorded |
| — | NCT03551561 Comparator | Jun → Nov 2017 | infectious disease | Universidade do Vale do Sapucai | Completed | No outcome recorded |
| — | NCT03063112 Comparator | Oct 2016 → Apr 2017 | digestive system cancer | South Egypt Cancer Institute | Unknown | No outcome recorded |
| — | NCT02710578 Comparator | Mar 2016 → Jul 2017 | — | Centre for Addiction and Mental Health | Completed | No outcome recorded |
Press releases naming this drug 12 releases
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 74 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Alcohol | “Other: alcohol, scopolamine, nicotine” NCT02033707 ↗ |
| Known as | dehydrated alcohol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00037141 ↗ |
| Known as | ethanol | “This study will test the reliability of a procedure for self-administering ethanol (alcohol) intravenously (through a vein)” NCT00713492 ↗ |
| Known as | Ethyl Alcohol | “An appropriate amount of 95% USP ethyl alcohol will be mixed in orange juice and tonic water to obtain a drink equivalent to 3-5 standard drinks.” NCT01638364 ↗ |
| Route | Other | “Transurethral Alcohol Injection” NCT00037141 ↗ |